Jefferson Capital, Inc. ((JCAP)) has held its Q4 earnings call. Read on for the main highlights of the call.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Jefferson Capital, Inc. struck an upbeat tone on its latest earnings call, pointing to record collections, revenue and deployments alongside sector‑leading efficiency and a stronger balance sheet. Management acknowledged rising legal and court costs, seasonal swings and macro pressures on consumers, but argued these are manageable against a backdrop of robust growth and disciplined underwriting.
Record Collections and Top-Line Acceleration
Jefferson Capital posted record fourth-quarter collections of $245 million, a 41% jump from a year earlier, powered by heavy deployments over 2023–2024 and new portfolios. The Conn’s purchase contributed $36 million and Bluestem added $14 million in the quarter, underscoring how recent strategic deals are already lifting cash generation.
Deployments Surge and ERC Reaches New High
The company also hit a record $381 million of portfolio deployments in Q4, up 6% year over year, laying the groundwork for future collections. Estimated remaining collections climbed to an all‑time high of $3.4 billion, up 23%, with $1.1 billion expected over the next 12 months and 58% due by 2027.
Revenue Growth and Profitability Momentum
Quarterly revenue reached a record $155 million, up 30% from the prior year, supported by strong asset performance and integration wins. Adjusted EPS came in at $0.69, while adjusted pretax income grew 15% to $51 million and adjusted cash EBITDA rose 34% to $178 million, signaling expanding earnings power.
Sector-Leading Operating Efficiency
Management highlighted a sector‑leading Q4 cash efficiency ratio of 71%, reflecting a lower cost to collect relative to peers and aided by the Conn’s and Bluestem portfolios. Even excluding those performing assets, cash efficiency was 68% in the quarter and 69.7% for the full year, reinforcing structural cost advantages.
Strengthened Capital Structure and Liquidity
Jefferson Capital further fortified its balance sheet by amending its revolving credit facility, lifting committed capital by $175 million to $1.0 billion and extending tenor at better pricing. Net debt to adjusted cash EBITDA improved to 1.9 times, below many competitors, with ample undrawn capacity and pre‑funded resources for its May 2026 bond repayment.
Strategic Deals Already Paying Off
The Bluestem acquisition, which closed in early December, and the Conn’s portfolio purchase have been fully integrated and are performing in line with expectations. Conn’s delivered $15.5 million of portfolio revenue, $1.3 million of servicing revenue and $10.7 million of NOI in Q4, while Bluestem contributed $5.4 million of revenue and $2.5 million of NOI.
Capital Returns and Shareholder-Focused Moves
On capital allocation, the company completed a follow‑on equity offering that boosted trading float and reduced J.C. Flowers’ stake to 53%, improving liquidity in the stock. It also repurchased around 3 million shares, about 5% of shares outstanding, for $59 million and declared a $0.24 quarterly dividend, implying a mid‑single‑digit yield.
Long-Term Growth Through Multiple Cycles
Management underscored a compelling long‑term track record from 2019 through 2025, with revenue growing at a 27% compound annual rate and net operating income rising 37% annually. Net income compounded at 43% over the same span, illustrating that the business has scaled profitably across different credit and rate environments.
Rising Legal Volumes Drive Higher Court Costs
One pressure point is a sharp increase in legal‑channel expenses, as court costs climbed to $17.7 million in Q4, up 86% year on year. These are front‑loaded expenditures tied to a growing inventory of suit‑eligible accounts, and management expects core court costs to stay elevated as it leans more on the legal collection channel.
Operating Expense Growth Tracks Scaling Effort
Overall operating expenses rose 30% year over year to $84 million in the quarter, reflecting both the higher legal spend and broader scale‑related costs. While expense growth lagged the 41% increase in collections, investors will watch whether the company can sustain this positive spread as deployment volumes and processing complexity grow.
Seasonality and ERC Rolloff Replacement Challenge
The business remains highly seasonal, with Q4 typically the peak for portfolio purchases and Q1 slower, which may introduce near‑term noise in results. With about $1.1 billion of ERC expected to roll off over the next 12 months and only roughly $225 million of forward‑flow commitments at year‑end, the firm estimates needing about $582 million of new deployments to fully replace runoff.
Efficiency Dependence on Performing Portfolios
Headline efficiency metrics benefited meaningfully from the lower‑cost, performing Conn’s and Bluestem portfolios, which pull up the overall cash efficiency ratio. Excluding these assets, Q4 efficiency would have been 68% and the full‑year figure 69.7%, hinting that the company’s top‑line efficiency is partly reliant on securing similar high‑quality, low‑cost portfolios.
Macro Headwinds and Consumer Strain
Executives flagged a more stressed consumer backdrop, with aggregate savings at $831 billion versus an inflation‑adjusted 2013–2019 average of $1.1 trillion. Rising insolvencies may increase supply for Jefferson Capital’s business, but they also raise the risk of credit deterioration, making disciplined underwriting and pricing critical.
Limited Near-Term Pricing Tailwinds
In some asset classes, particularly prime credit card portfolios, management reported little improvement in pricing despite modest increases in supply. This suggests limited near‑term upside from better purchase multiples in those markets and reinforces the need to drive returns more through operational discipline than cheaper assets.
Guidance and Outlook: Growth with Elevated Legal Spend
Looking forward, Jefferson Capital expects Bluestem to be a meaningful earnings contributor in 2026 and plans to collect $1.1 billion of its $3.4 billion ERC over the next year, while targeting roughly $582 million in new deployments to offset runoff. The company plans to operate with net leverage between 2.0 and 2.5 times over the long run, maintain strong liquidity under its $1.0 billion revolver, keep quarterly dividends at $0.24 per share and deliver underlying cash efficiency in the high‑60% range even as legal‑channel costs remain elevated.
Jefferson Capital’s earnings call painted a picture of a company balancing rapid growth, strategic deals and shareholder returns against rising legal costs, seasonality and a fragile consumer environment. For investors, the key takeaway is that strong collections, a solid balance sheet and a proven growth record currently outweigh the headwinds, but execution on future deployments and cost control will be critical to sustaining this momentum.

